BSE Live
Oct 14, 15:54Prev. Close
439.90
Open Price
439.90
Bid Price (Qty.)
440.00 (1)
Offer Price (Qty.)
444.00 (16)
NSE Live
Oct 14, 15:59Prev. Close
440.20
Open Price
435.00
Bid Price (Qty.)
444.70 (19)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -135.97 | 37.18 | -61.23 | -84.04 | 1.40 | |
Net CashFlow From Operating Activities | -82.86 | 107.16 | 172.06 | 103.84 | 97.85 | |
Net Cash Used In Investing Activities | -18.52 | -8.33 | -2.73 | -17.92 | 22.74 | |
Net Cash Used From Financing Activities | 109.39 | -98.45 | -163.67 | -91.06 | -128.69 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 8.02 | 0.37 | 5.66 | -5.15 | -8.09 | |
Cash And Cash Equivalents Begin of Year | 6.90 | 4.59 | 0.86 | 6.01 | 14.13 | |
Cash And Cash Equivalents End Of Year | 14.92 | 4.96 | 6.52 | 0.86 | 6.04 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y